A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics (Q46755100)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16227145

A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16227145

0 references

object named as

John V McMurray

6

0 references

1

object named as

John Kjekshus

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

Peter H J M Dunselman

2

object named as

Peter Dunselman

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16227145

Åke Hjalmarson

5

object named as

Ake Hjalmarson

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16227145

10

object named as

John Wikstrand

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16227145

author name string

Malin Blideskog

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16227145

Christina Eskilson

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16227145

Finn Waagstein

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16227145

Hans Wedel

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16227145

Peter Wessman

9

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16227145

CORONA Study Group

11

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16227145

publication date

1 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16227145

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16227145

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16227145

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16227145

1059-1069

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16227145

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

Statins and chronic heart failure: do we need a large-scale outcome trial?

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

Heart failure and statins--why do we need a clinical trial?

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

Total cholesterol and risk of mortality in the oldest old.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

Skin test anergy in advanced heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

The relationship between cholesterol and survival in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

Endotoxin and immune activation in chronic heart failure: a prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

The endotoxin-lipoprotein hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

The clinical use of HMG CoA-reductase inhibitors and the associated depletion of coenzyme Q10. A review of animal and human publications

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

Effect of atorvastatin on left ventricular diastolic function and ability of coenzyme Q10 to reverse that dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

Statin-associated myopathy with normal creatine kinase levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

Risk for myopathy with statin therapy in high-risk patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

Rosuvastatin reduces MMP-7 secretion by human monocyte-derived macrophages: potential relevance to atherosclerotic plaque stability.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

Statins do more than just lower cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.005

21 January 2018

Identifiers

10.1016/J.EJHEART.2005.09.005

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16227145

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16227145

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46755100&oldid=2129904291"